ArticleFrontiers in allergy2021
Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.
- Precision Medicine in Plant Food Allergy: a Systematic Review of Biomarkers Under a Clinical Approach.Clinical reviews in allergy & immunology · 2026Pooled it
- Risk factors for severe reactions in food allergy: Rapid evidence review with meta-analysis.Allergy · 2022Pooled it
- Review
- Clinical and immunological markers of peanut allergy severity and tolerance in children.Frontiers in allergy · 2026Article
- Prediction of food allergy reaction severity: biomarkers and host factors.Frontiers in allergy · 2025Review
- Viral Vector Based Immunotherapy for Peanut Allergy.Viruses · 2024Review
- Risk Factors for Anaphylaxis in Children Allergic to Peanuts.Medicina (Kaunas, Lithuania) · 2023Article
- Article
- Food anaphylaxis diagnostic marker compilation in machine learning design and validation.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors at 20 institutions in 15 countries.
Mareen R DatemaDepartment of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Sarah A LyonsDepartment of Dermatology and Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Montserrat Fernández-RivasAllergy Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitario San Carlos, Madrid, Spain.
Barbara Ballmer-WeberAllergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland.
André C KnulstDepartment of Dermatology and Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Riccardo AseroAmbulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy.
Laura BarrealesClinical Epidemiology Unit, Preventive Medicine Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitario San Carlos, Madrid, Spain.
Simona BelohlavkovaDepartment of Allergology and Immunology, Faculty of Medicine in Pilsen, Charles University, Prague, Czechia.
Frédéric de BlayAllergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France.
Michael ClausenFaculty of Medicine, Landspitali University Hospital, University of Iceland, Reykjavik, Iceland.
Ruta DubakieneMedical Faculty, Vilnius University, Vilnius, Lithuania.
Cristina Fernández-PerezClinical Epidemiology Unit, Preventive Medicine Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitario San Carlos, Madrid, Spain.
Philipp FritscheAllergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland.
David GislasonFaculty of Medicine, Landspitali University Hospital, University of Iceland, Reykjavik, Iceland.
Karin Hoffmann-SommergruberDepartment of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Monika Jedrzejczak-CzechowiczDepartment of Immunology, Rheumatology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Laurian JongejanDepartment of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Marek L KowalskiDepartment of Immunology, Rheumatology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
Tanya Z KralimarkovaClinical Center of Allergology, Medical University of Sofia, Sofia, Bulgaria.
Jonas LidholmThermo Fisher Scientific, Uppsala, Sweden.
Nikolaos G PapadopoulosAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
Todor A PopovClinic of Occupational Diseases, University Hospital Sv. Ivan Rilski, Sofia, Bulgaria.
Nayade Del PradoClinical Epidemiology Unit, Preventive Medicine Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitario San Carlos, Madrid, Spain.
Ashok PurohitAllergy Division, Chest Disease Department, Strasbourg University Hospital, Strasbourg, France.
Isabel ReigAllergy Department, Hospital Clinico San Carlos, Instituto de Investigacion Sanitario San Carlos, Madrid, Spain.
Suranjith L SeneviratneInstitute of Immunity and Transplantation, University College London, London, United Kingdom.
Athanassios SinaniotisAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
Emilia VassilopoulouDepartment of Nutritional Sciences and Dietetics, International Hellenic University, Thessaloniki, Greece.
Serge A VersteegDepartment of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Stefan ViethsPaul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
Paco M J WelsingDivision of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
E N Clare MillsDivision of Infection, Immunity and Respiratory Medicine, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Thuy-My LeDepartment of Dermatology and Allergology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Aeilko H ZwindermanDepartment of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam University Medical Center, Amsterdam, Netherlands.
Ronald van ReeDepartment of Experimental Immunology, Amsterdam University Medical Center, Amsterdam, Netherlands.
Hospital Clínico San Carlos · ESAmsterdam University Medical Centers · NLUtrecht University · NLMedical University of Lodz · PLUniversité de Strasbourg · FRUniversity of Manchester · GBCharles University · CZInternational Hellenic University · GRKantonsspital St. Gallen · CHMedical University of Sofia · BGMedical University of Vienna · ATNational and Kapodistrian University of Athens · GRNational University Hospital of Iceland · ISOspedale San Carlo · ITPaul Ehrlich Institut · DEThermo Fisher Scientific (Sweden) · SEUniversity College London · GBUniversity Hospital of Zurich · CHUniversity Hospital St. Ivan Rilski · BGUniversity Medical Center Utrecht · NL
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
clinical backgroundcomponent-resolved diagnosticsEuroPrevalliFAAMIgEpeanut allergypredictionseverity
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.